Literature DB >> 10966968

Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.

O Cekiç1, C Batman, U Yaşar, N E Başci, O Zilelioğlu, A Bozkurt.   

Abstract

AIMS: To investigate the subretinal fluid (SRF) penetration of ciprofloxacin following topical, oral, and combined administration.
METHODS: 34 patients undergoing conventional retinal reattachment surgery were randomly assigned to three groups. Twelve patients received topical ciprofloxacin, 11 patients received oral ciprofloxacin, and the other 11 patients received combined drug administration. SRF drug level was measured by using high performance liquid chromatography method.
RESULTS: The highest drug concentrations of all tested modes were attained following combined administration and lowest following topical administration (p<0.001). The SRF drug concentration following oral administration was also significantly higher than that of topical administration (p<0.001). Concentrations after oral and combined administration did not differ significantly (p = 0.217).
CONCLUSIONS: Topical ciprofloxacin can penetrate SRF. Ocular bioavailability of ciprofloxacin in SRF after oral and combined administration is equivalent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966968      PMCID: PMC1723621          DOI: 10.1136/bjo.84.9.1061

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.

Authors:  F Oztürk; S Kortunay; E Kurt; S S Ilker; N E Basci; A Bozkurt
Journal:  Retina       Date:  1999       Impact factor: 4.256

2.  The intravitreal penetration of orally administered ciprofloxacin in humans.

Authors:  G Keren; A Alhalel; E Bartov; R Kitzes-Cohen; E Rubinstein; S Segev; G Treister
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-07       Impact factor: 4.799

3.  [Intraocular penetration of ciprofloxacin after infusion and oral administration].

Authors:  M Mounier; J P Adenis; F Denis
Journal:  Pathol Biol (Paris)       Date:  1988-06

4.  Intravitreal penetration of oral ciprofloxacin in humans.

Authors:  F Z el Baba; M D Trousdale; W J Gauderman; D G Wagner; P E Liggett
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

Review 5.  Antibacterial agents in the treatment of ocular infections.

Authors:  M Barza
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

6.  Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.

Authors:  O Cekiç; C Batman; Y Totan; U Yasar; N E Basci; A Bozkurt; S O Kayaalp
Journal:  Ophthalmic Surg Lasers       Date:  1999-06

7.  Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.

Authors:  O Cekiç; C Batman; Y Totan; U Yasar; N E Basci; A Bozkurt; S O Kayaalp; O Zilelioglu
Journal:  Eye (Lond)       Date:  1999-10       Impact factor: 3.775

8.  Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration.

Authors:  O Cekiç; C Batman; U Yasar; N E Başci; A Bozkurt; S O Kayaalp
Journal:  Eye (Lond)       Date:  1999-08       Impact factor: 3.775

9.  The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.

Authors:  M R Lesk; H Ammann; G Marcil; B Vinet; L Lamer; M Sebag
Journal:  Am J Ophthalmol       Date:  1993-05-15       Impact factor: 5.258

10.  Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis.

Authors:  J A Hobden; R J O'Callaghan; M S Insler; J M Hill
Journal:  Cornea       Date:  1993-03       Impact factor: 2.651

View more
  2 in total

1.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

2.  Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.

Authors:  Seung Yong Choi; Hyun-A Lim; Hyeon Woo Yim; Young-Hoon Park
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.